Position in ABVX
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$1,974,903
+$1,555,504 QoQ
Shares Held
17,736
+470.3% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIVERSIFY WEALTH MANAGEMENT, LLC holds $21,079,655 across 12 Biotechnology names. ABVX ranks #4 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
22,232 | $9,927,477 | |
| 2 | ASND |
Ascendis Pharma A/S
|
10,675 | $2,441,692 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
31,504 | $2,036,103 | |
| 4 | ABVX |
Abivax S.A.
This page
|
17,736 | $1,974,903 | |
| 5 | ARGX |
Argenx SE
|
1,884 | $1,375,791 | |
| 6 | DBVT |
DBV Technologies S.A.
|
63,672 | $1,330,108 | |
| 7 | GMAB |
Genmab A/S
|
46,564 | $1,249,312 | |
| 8 | INSM |
INSMED Inc
|
1,704 | $278,638 |
All Filings in ABVX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,974,903 | 17,736 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $419,399 | 3,110 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||